Antifibrotic therapies in rheumatoid arthritis associated interstitial lung disease
Diagnostic and interventional radiology (Ankara, Turkey), cilt.9, sa.3, ss.176-179, 2022 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 9 Sayı: 3
- Basım Tarihi: 2022
- Doi Numarası: 10.5152/eurjrheum.2021.21102
- Dergi Adı: Diagnostic and interventional radiology (Ankara, Turkey)
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.176-179
- Anahtar Kelimeler: Lung diseases, interstitial, arthritis, rheumatoid, therapeutics
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Interstitial lung disease (ILD) is one of the common extra-articular manifestations of rheumatoid arthritis (RA) and it is associated with high mortality rate. The usual interstitial pneumonia (UIP) pattern of RA associated ILD (RA-ILD) shows some similarities to idiopathic pulmonary fibrosis, suggesting that antifibrotic therapies may have potential positive affects. In this review, we discuss the effectiveness of antifibrotic therapy for RA-ILD.